採用

Senior Director, Clinical Pharmacology and Translational PK/PD
San Francisco, California, United States
·
On-site
·
Full-time
·
5d ago
Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITY
Vir Biotechnology is looking for an experienced Sr. Director of Clinical Pharmacology and Translational PK/PD to lead the technical and operational aspects of the department in support of programs across all stages of preclinical and clinical development. You will work across Vir Bio's portfolio of infectious disease and oncology programs, providing hands-on leadership while managing and developing a team. In this role, you will work collaboratively with internal and external cross-functional teams and consultants to support the successful and timely advancement of drug development programs. You will evaluate and apply best practices and innovative techniques to foster successful execution and outcomes of clinical studies. You will report to the VP of Translational Development.
This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.
WHAT YOU'LL DO
- Oversee clinical pharmacology and translational PK/PD operations and deliverables across all stages of development for both infectious disease and oncology programs
- Represent clinical pharmacology and translational PK/PD as technical expert on cross-functional project teams and provide strategic input to program advancement
- Develop fit-for-purpose clinical pharmacology strategies to enable development and regulatory decisions from pre-IND through market authorization
- Select and execute appropriate modeling and simulation approaches (PK/PD, PopPK, exposure-response) to inform dose selection, optimization, and justification for Phase 2 and pivotal trials
- Author and provide technical input for regulatory documents and submissions (protocols, IBs, briefing packages, INDs, NDAs/BLAs) and responses to questions
- Work collaboratively with cross-functional teams, including clinical research, clinical operations, biomarkers, bioanalytical, biometrics, CMC, research, and regulatory in support of program advancement
- Establish and manage collaborations with external vendors and collaborating partners
- Generate and manage departmental budget(s) and optimize resource allocation across multiple programs
- Manage and develop the Clinical Pharmacology and Translational PK/PD team, including hiring, mentoring, and building departmental capabilities to support organizational needs
WHO YOU ARE AND WHAT YOU BRING
- PhD, PharmD, or MD with relevant training in clinical pharmacology, pharmacokinetics, pharmaceutics, or related field with 13+ years industry experience in Clinical Pharmacology, DMPK and/or related fields
- Mastery of nonclinical and clinical pharmacokinetic concepts and methodologies with deep understanding of multidisciplinary drug development requirements
- Expertise in PK/PD, PopPK and exposure-response modeling with proficiency in R and extensive hands-on experience with Monolix or NONMEM
- Extensive experience leading translational and clinical pharmacology work from FIH dose selection through market authorization
- Strong understanding of regulatory requirements and experience contributing to regulatory submissions and engagements
- Working knowledge of bioanalytical techniques in support of clinical development of small molecules and biologics
- Experience with biologics, including monoclonal antibodies and bispecifics required; experience in oncology and/or infectious disease indications strongly preferred
- Proficiency using standard PK analysis and graphing programs (Phoenix WNL, Graphpad, R, etc.)
- Proven ability to manage and develop teams
WHO WE ARE AND WHAT WE OFFER
The expected salary range for this position is $235,500 to $329,500 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Director, Clinical Research
Hinge Health · San Francisco-HQ

Clinical Success Director
Abridge · SF Office

Pharmacy Manager (Pharmacist)
Albertsons · San Francisco, CA, United States, US

Commercial Banker-Healthcare, Higher Education & Non-Profit, Middle Market Banking-Vice President
JPMorgan Chase · San Francisco, CA, United States, US

Investment Banker - Healthcare Biopharma - Executive Director
JPMorgan Chase · San Francisco, CA, United States, US
Vir Biotechnologyについて

Vir Biotechnology
PublicAn immunology company that develops products to treat and prevent infectious diseases and other serious conditions.
201-500
従業員数
San Francisco
本社所在地
$1.2B
企業価値
レビュー
3.7
10件のレビュー
ワークライフバランス
3.2
報酬
2.8
企業文化
4.1
キャリア
3.8
経営陣
3.0
65%
友人に勧める
良い点
Supportive and collaborative team culture
Cutting-edge research and meaningful work
Professional development opportunities
改善点
Heavy workload and frequent overtime
Management lacks clear direction and communication
Fast-paced and high-pressure environment
給与レンジ
23件のデータ
Junior/L3
Senior/L5
Junior/L3 · Statistician I, Biostatistics
1件のレポート
$155,250
年収総額
基本給
$135,000
ストック
-
ボーナス
-
$155,250
$155,250
面接体験
43件の面接
難易度
3.3
/ 5
期間
14-28週間
内定率
35%
体験
ポジティブ 63%
普通 27%
ネガティブ 10%
面接プロセス
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
よくある質問
Technical skills
Past experience
Team collaboration
Problem solving
ニュース&話題
Buy Signal Vir Biotechnology Inc - 24 Apr 2026 @ 12:26 -> USD10.21
Ticker: **VIR** Exchange: **NASDAQ** Time: **24 Apr 2026 @ 12:26** Price: **USD10.21** Link: https://getagraph.com/NASDAQ/stock/live-signals/VIR/ENG
·
5d ago
·
1
Buy Signal Vir Biotechnology Inc - 24 Apr 2026 @ 10:51 -> USD10.17
Ticker: **VIR** Exchange: **NASDAQ** Time: **24 Apr 2026 @ 10:51** Price: **USD10.17** Link: https://getagraph.com/NASDAQ/stock/live-signals/VIR/ENG
·
5d ago
·
1
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results - BioSpace
BioSpace
News
·
6d ago
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
·
6d ago
·
1